The Wnt ligands secreted by tumour cells activate the transformation of CD4(+) T cells to Treg cells by promoting the expression of β-catenin expressions in DCs, reducing the burden on tumour metabolic burden (145, 146). This evidence concerns the gene CD4 and neoplasm.